Literature DB >> 25793895

The liver in heart failure: a biopsy and explant series of the histopathologic and laboratory findings with a particular focus on pre-cardiac transplant evaluation.

Christine Y Louie1, Michael X Pham2, Tami J Daugherty3, Neeraja Kambham1, John P T Higgins1.   

Abstract

The pathologic liver changes in chronic heart failure have been characterized mostly based on autopsy series and include sinusoidal dilation and congestion progressing to pericellular fibrosis, bridging fibrosis, and ultimately to cardiac cirrhosis or sclerosis. Liver biopsies are commonly obtained as part of the work up before heart transplantation in patients with longstanding right heart failure, particularly if ascites, abnormal liver function tests or abnormal abdominal imaging are noted as part of the pre-transplant evaluation. In these cases, the liver biopsy findings may be used to further risk stratify patients for isolated heart or combined heart and liver transplantation. Thus, it is important to be able to correlate the histologic changes with post-transplant outcomes. We report the pathologic and clinical findings in liver explants from six patients who underwent combined heart-liver transplantation. We also report preoperative liver biopsy findings from 21 patients who underwent heart transplantation without simultaneous liver transplantation. We staged the changes related to chronic passive congestion as follows: stage 0-no fibrosis; stage I-pericellular fibrosis; stage II-bridging fibrosis; and stage III-regenerative nodules. Nineteen biopsies showed fibrosis with bridging fibrosis in 13 and regenerative nodules in 6. Fifteen patients were alive at 1 year post transplant. Only three patients had a post-operative course that was characterized by signs and symptoms of chronic liver disease. Pre-transplant liver biopsies from these patients all showed at least stage II fibrosis. These patients survived for 3, 6, and 10 months after cardiac transplant. The presence of bridging fibrosis was not significantly associated with post-operative survival (P=0.336) or post-operative liver failure (P=0.257). We conclude that patients with bridging fibrosis may still be considered viable candidates for isolated heart transplantation. Because the pattern of fibrosis due to passive congestion is highly variable throughout the liver, a diagnosis of cirrhosis, which implies fibrosis and regenerative nodules throughout the liver, should be made with great caution on biopsy.

Entities:  

Mesh:

Year:  2015        PMID: 25793895     DOI: 10.1038/modpathol.2015.40

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  25 in total

Review 1.  A review of the United States experience with combined heart-liver transplantation.

Authors:  Robert M Cannon; Michael G Hughes; Christopher M Jones; Mary Eng; Michael R Marvin
Journal:  Transpl Int       Date:  2012-09-02       Impact factor: 3.782

2.  Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction.

Authors:  Aalap Chokshi; Faisal H Cheema; Kenneth J Schaefle; Jeffrey Jiang; Elias Collado; Khurram Shahzad; Tuba Khawaja; Maryjane Farr; Hiroo Takayama; Yoshifumi Naka; Donna M Mancini; P Christian Schulze
Journal:  J Heart Lung Transplant       Date:  2012-03-27       Impact factor: 10.247

3.  Cardiac hepatopathy before and after heart transplantation.

Authors:  Wolfgang Dichtl; Wolfgang Vogel; Karin M Dunst; Wilhelm Grander; Hannes F Alber; Matthias Frick; Herwig Antretter; Günther Laufer; Otmar Pachinger; Gerhard Pölzl
Journal:  Transpl Int       Date:  2005-06       Impact factor: 3.782

Review 4.  Cardiohepatic interactions in heart failure: an overview and clinical implications.

Authors:  Marc D Samsky; Chetan B Patel; Tracy A DeWald; Alastair D Smith; G Michael Felker; Joseph G Rogers; Adrian F Hernandez
Journal:  J Am Coll Cardiol       Date:  2013-04-17       Impact factor: 24.094

5.  Heart transplantation in patients with end-stage heart failure and cardiac ascites.

Authors:  Ron-Bin Hsu
Journal:  Circ J       Date:  2007-11       Impact factor: 2.993

Review 6.  The liver in heart failure.

Authors:  Cosmas C Giallourakis; Peter M Rosenberg; Lawrence S Friedman
Journal:  Clin Liver Dis       Date:  2002-11       Impact factor: 6.126

7.  Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis).

Authors:  I R Wanless; J J Liu; J Butany
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

8.  Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.

Authors:  Margaret S Kim; Tomoko S Kato; Maryjane Farr; Christina Wu; Raymond C Givens; Ellias Collado; Donna M Mancini; P Christian Schulze
Journal:  J Am Coll Cardiol       Date:  2013-04-03       Impact factor: 24.094

9.  Morphologic features of hepatic injury in cardiac disease and shock.

Authors:  J H Lefkowitch; L Mendez
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

10.  Predicting outcome after cardiac surgery in patients with cirrhosis: a comparison of Child-Pugh and MELD scores.

Authors:  Amitabh Suman; David S Barnes; Nizar N Zein; Gavin N Levinthal; Jason T Connor; William D Carey
Journal:  Clin Gastroenterol Hepatol       Date:  2004-08       Impact factor: 11.382

View more
  17 in total

1.  Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.

Authors:  Alexander Lemmer; Lisa VanWagner; Zaira Gasanova; Steve Helmke; Gregory T Everson; Daniel Ganger
Journal:  Congenit Heart Dis       Date:  2019-08-01       Impact factor: 2.007

Review 2.  Congestive hepatopathy: Differentiating congestion from fibrosis.

Authors:  Alexander Lemmer; Lisa VanWagner; Daniel Ganger
Journal:  Clin Liver Dis (Hoboken)       Date:  2018-01-02

Review 3.  The influence of heart failure on the pharmacokinetics of cardiovascular and non-cardiovascular drugs: a critical appraisal of the evidence.

Authors:  Arduino A Mangoni; Elzbieta A Jarmuzewska
Journal:  Br J Clin Pharmacol       Date:  2018-10-14       Impact factor: 4.335

4.  Fatal Pertussis in the Neonatal Mouse Model Is Associated with Pertussis Toxin-Mediated Pathology beyond the Airways.

Authors:  Karen M Scanlon; Yael G Snyder; Ciaran Skerry; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 5.  Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients With Congestive Hepatopathy.

Authors:  Alexander Lemmer; Lisa B VanWagner; Daniel Ganger
Journal:  Hepatology       Date:  2018-09-22       Impact factor: 17.425

6.  Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study.

Authors:  Atsushi Okada; Hideaki Kanzaki; Yasuhiro Hamatani; Seiji Takashio; Hiroyuki Takahama; Makoto Amaki; Takuya Hasegawa; Yasuo Sugano; Satoshi Yasuda; Toshihisa Anzai
Journal:  Heart Vessels       Date:  2017-11-02       Impact factor: 2.037

7.  Hspb7 is a cardioprotective chaperone facilitating sarcomeric proteostasis.

Authors:  Emily J Mercer; Yi-Fan Lin; Leona Cohen-Gould; Todd Evans
Journal:  Dev Biol       Date:  2018-01-10       Impact factor: 3.582

8.  Comparison of combined heart‒liver vs heart-only transplantation in pediatric and young adult Fontan recipients.

Authors:  Danielle Sganga; Seth A Hollander; Sumeet Vaikunth; Christiane Haeffele; Rachel Bensen; Manchula Navaratnam; Nancy McDonald; Elizabeth Profita; Katsuhide Maeda; Waldo Concepcion; Daniel Bernstein; Sharon Chen
Journal:  J Heart Lung Transplant       Date:  2020-12-29       Impact factor: 10.247

Review 9.  From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?

Authors:  Anna Sessa; Manon Allaire; Pascal Lebray; Mourad Medmoun; Alberto Tiritilli; Pierre Iaria; Jean-François Cadranel
Journal:  JHEP Rep       Date:  2021-01-27

10.  Pathological alterations in liver injury following congestive heart failure induced by volume overload in rats.

Authors:  Mohammed Shaqura; Doaa M Mohamed; Noureddin B Aboryag; Lama Bedewi; Lukas Dehe; Sascha Treskatsch; Mehdi Shakibaei; Michael Schäfer; Shaaban A Mousa
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.